Anyone considering GLP-1 medication should seek an evaluation from a licensed healthcare provider who takes a complete history, and should treat any process that skips that step as a warning sign rather than a convenience.
These include Alzheimers Disease where neuroprotective effects are under investigation followed by stroke under similar notion (125) Futhermore, in non-alcoholic fatty liver disease (NAFLD) they show evidence of improved liver histology and hepatic steatosis (126) in PCOS they may help in regulation of weight, reproductive and metabolic parameters simultaneously (127) GLP1-Ras are also under study with their ability to modulate the hemodynamic and inflammatory pathways to treat CKD (128) and Heart failure (129)
According to a study, eating a lot of monounsaturated fats may increase the release of GLP-1
The key to success lies in starting with established protocols, monitoring your response carefully, and making informed adjustments based on your unique biology and goals
Practical timing considerations include ensuring patients can commit to weekly injections and follow-up appointments, verifying insurance coverage or discussing out-of-pocket costs before initiation, scheduling initiation when patients can manage potential gastrointestinal side effects (avoiding major life events, travel, or work commitments in the first 4-8 weeks), and confirming patients are not planning pregnancy in the near term